收藏切换
Therapeutic prospect of tetrandrine against SARS-CoV-2 based on its pulmonary pharmacology and exposure character
收藏切换
PDF
Fu-run WANG, Wen-peng ZHANG, Ri-gao DING, Wu ZHONG*, Xiao-mei ZHUANG*
Acta Pharmaceutica Sinica | 2021, 56(7) : 1769 - 1777
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(7): 1769-1777
Special Reports: Focalizing on the research of the quality control and in vivo process of natural drugs
Therapeutic prospect of tetrandrine against SARS-CoV-2 based on its pulmonary pharmacology and exposure character
Full
Fu-run WANG, Wen-peng ZHANG, Ri-gao DING, Wu ZHONG*, Xiao-mei ZHUANG*
Affiliations
  • Academy of Military Sciences, Academy of Military Medical Sciences, Institute of Pharmacology and Toxicology, Beijing 100850, China
Published: 2021-07-12 doi: 10.16438/j.0513-4870.2021-0594
Outline
收藏切换

As the main active compound of Stephania tetrandra S. Moore, tetrandrine (TET) has been used to treat silicosis for nearly 50 years. TET has clear therapeutic effect on pulmonary fibrosis and lung cancer. A recent study suggests that TET may inhibit the replication of SARS-CoV-2 by blocking the two-pore channel 2 (TPC2), revealing its potential as a natural medicine to treat COVID-19. To explore the material basis of TET targeting lung efficacy and its potential toxicity, available literatures related to the pharmacological activity on pulmonary, dosage, toxicity and pharmacokinetics of TET are systemically reviewed. The prospect and current problems of TET to be a therapeutic agent for COVID-19 are further investigated on this basis.

tetrandrine  /  pharmacokinetics  /  pulmonary exposure  /  COVID-19  /  natural medicine
Fu-run WANG, Wen-peng ZHANG, Ri-gao DING, Wu ZHONG, Xiao-mei ZHUANG. Therapeutic prospect of tetrandrine against SARS-CoV-2 based on its pulmonary pharmacology and exposure character[J]. Acta Pharmaceutica Sinica, 2021 , 56 (7) : 1769 -1777 . DOI: 10.16438/j.0513-4870.2021-0594
Year 2021 volume 56 Issue 7
PDF
131
55
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-0594
  • Receive Date:2021-04-22
  • Online Date:2025-12-18
  • Published:2021-07-12
Article Data
Affiliations
History
  • Received:2021-04-22
  • Revised:2021-05-20
Funding
Affiliations
    Academy of Military Sciences, Academy of Military Medical Sciences, Institute of Pharmacology and Toxicology, Beijing 100850, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-0594
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT